Paul D. Rubin
2014 - XOMA
In 2014, Paul D. Rubin earned a total compensation of $1.8M as Former Senior Vice President Research and Development and Chief Medical Officer at XOMA, a 134% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $146,125 |
---|---|
Option Awards | $629,983 |
Salary | $410,970 |
Stock Awards | $612,946 |
Other | $11,406 |
Total | $1,811,430 |
Rubin received $630K in option awards, accounting for 35% of the total pay in 2014.
Rubin also received $146.1K in non-equity incentive plan, $411K in salary, $612.9K in stock awards and $11.4K in other compensation.
Rankings
In 2014, Paul D. Rubin's compensation ranked 4,917th out of 13,032 executives tracked by ExecPay. In other words, Rubin earned more than 62.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,917 out of 13,032 | 62nd |
Division Manufacturing | 1,755 out of 4,966 | 65th |
Major group Chemicals And Allied Products | 581 out of 1,686 | 66th |
Industry group Drugs | 443 out of 1,365 | 68th |
Industry Pharmaceutical Preparations | 353 out of 1,043 | 66th |
Source: SEC filing on April 5, 2017.
Rubin's colleagues
We found four more compensation records of executives who worked with Paul D. Rubin at XOMA in 2014.